Sign in to view content

Faricimab Reduces Macular Leakage vs Aflibercept in Patients With DME

Eric Nudleman, MD, PhD

Video
Published 2023

Related

Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker For the Treatment of Diabetic Macular Edema (DME)
Victor Hugo Gonzalez, MD
Annual Meeting Talks
2024
Episode 113: Journal Club, Macular Ischemia in RISE/RIDE, Wet Conversion in AMD, Micropulse for CSR
Jayanth Sridhar, MD
Member Podcasts
2018
Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch
Estephania Feria, MD
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more